Source: International Congress 2015 – Connective tissue disorders
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yoshihiko Taniguchi (Sakai city, Osaka, Japan), Yoshihiko Taniguchi, Chikatoshi Sugimoto, Toru Arai, Taisuke Tsuji, Kazunobu Tachibana, Masanori Akira, Masanori Kitaichi, Seiji Hayashi, Yoshikazu Inoue. Recurrence predictive factors of cryptogenic organizing pneumonia. Eur Respir J 2015; 46: Suppl. 59, 3804

Member's Comments

No comment yet.

Related content which might interest you: Cryptogenic organising pneumonia focusing on its prognostic determinants Source: International Congress 2014 – ILDs 4 Year: 2014 Relapse predictive factors of chronic eosinophilic pneumonia Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia Source: International Congress 2014 – ILDs 4 Year: 2014 Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 6 Year: 2014 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Serum procalcitonin is useful in differentiating between drug-induced pneumonitis and bacterial pneumonia Source: International Congress 2014 – ILDs 5 Year: 2014 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Factors predicting resolution in nitrofurantoin-induced lung disease Source: International Congress 2016 – Orphan diseases II Year: 2016 Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Clinicopathological features of the pulmonary aspergillosis with chronic interstitial pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia Source: ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019 Year: 2020 Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia Source: International Congress 2017 – Lung function testing Year: 2017 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 2 Year: 2014